Emre Yekedüz - Concepedia

Author

Emre Yekedüz

Also Known As

E. Yekeduz, E. Yekedüz, E., Yekedüz, EMRE YEKEDÜZ, Emre YEKEDÜZ, Emre Yekeduz, Emre Yekedüz, Serhad Bilim, YEKEDÜZ, Emre, emre yekedüz

135

Publications

583

Citations

H-Index

Concepts

All Affiliations

Ankara University Hacettepe University Sağlık Bilimleri Üniversitesi Ankara Yıldırım Beyazıt University Ankara Onkoloji Eğitim ve Araştırma Hastanesi

About

Emre Yekedüz is an author at Ankara University specializing in oncology, medicine, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	104
2	Immunology	2	2	50
3	Health Sciences	1	1	22
4	Radiation Medicine	1	1	22
5	Antibiotics	1	1	32

Emre Yekedüz

Publications

241

Citations

H-Index

Page 1

	Year	Citations
The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study Deniz Can Güven, Ramazan Acar, Emre Yekedüz, Current Problems in Cancer UrologyAntibioticsAntimicrobial StewardshipMedicineAntibiotic Use	2021	32
Evaluation of cancer risk in patients with periodontal diseases Deniz Can Güven, Ömer Dızdar, Abdullah C. Akman, TURKISH JOURNAL OF MEDICAL SCIENCES	2019	29
Prognostic role of pan‐immune‐inflammation value in patients with metastatic castration‐resistant prostate cancer treated with androgen receptor‐signaling inhibitors Satı Coşkun Yazgan, Emre Yekedüz, Güngör Utkan, The Prostate	2022	27
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab Emre Yekedüz, Bengü Dursun, Güle Aydın, Journal of Oncology Pharmacy Practice ImmunologyImmunotherapeuticsOlder AgeDermatologyAntiviral Drug	2020	26
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study Emre Yekedüz, Deniz Tural, İsmail Ertürk, Journal of Cancer Research and Clinical Oncology Pan-immune-inflammation ValueUrologySurvival OutcomesCancer ImmunosurveillanceGenitourinary Cancer	2022	24
Assessing population diversity in phase <scp>III</scp> trials of cancer drugs supporting Food and Drug Administration approval in solid tumors Emre Yekedüz, Dario Trapani, Wenxin Xu, International Journal of Cancer	2021	22
The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study Elvina Almuradova, Mustafa Seyyar, Hacı Arak, International Journal of Cancer UrologyRadiation MedicineLu-177 Psma-617 RltGenitourinary CancerReal‐world Outcomes	2023	22
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors Kadriye Bır Yucel, Emre Yekedüz, Serdar Karakaya, Scientific Reports	2022	15
Perceptions, Attitudes, and Concerns on Artificial Intelligence Applications in Patients with Cancer Enes Erul, Yusuf Aktekin, Furkan Berk Danışman, Cancer Control	2025	12
Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer Emre Yekedüz, Ömer Dızdar, Neyran Kertmen, Journal of Clinical Medicine	2022	11

Page 1